Zoetis Inc
ZTS
$78.44+4.18%
End of day · as of Oct 15, 2026, 5:30 PM ET
Mkt cap
$64.65B
EV/Sales
N/A
P/E ratio
12.9
FY2025 Revenue
$9.47B
EPS (TTM)
$6.08
Gross Margin (FY2025)
71.84%
Profit Margin (FY2025)
28.23%
Beta
0.89
Div yield
1.28%
Sector
Healthcare
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ZTS revenue for 2025-12-31 was $9.47B. Net income was $2.67B. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. ZTS currently screens at market cap $64.65B and trailing P/E 12.9.
Use this ZTS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ZTS income, balance, and cash tables.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Zoetis Inc (ZTS) revenue for Dec 31, 2025 was $9.47B. Net income was $2.67B. Statements: https://lician.com/financials/zts
Zoetis Inc (ZTS) trailing P/E is 12.9 on the latest cached fundamentals snapshot.
Zoetis Inc (ZTS) market capitalization is $64.65B on the latest cached snapshot.
Zoetis Inc (ZTS) cached previous close $75.29; day range $76.70 – $78.44; volume 4,705,439. Session quote: https://lician.com/quote/zts
Zoetis Inc (ZTS) latest cached earnings event is "ZTS earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ZTS filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/zts